Pharm - Diabetes Flashcards
(33 cards)
renal failure, avoid
metformin (lactic acidosis)
glyburide
SGLT-2 inhib
HF, avoid
thiazolidinediones (fluid retention)
Biguanides
Metformin
Sulfonylureas
(“insulin secretagogues”)
glyburide
glipizide
glimepiride
meglitinides
(“insulin secretagogues”)
repaglinde
nateglinide
thiazolidinediones
piglitazone
rosglitazone
glucosidase inhibitors
acarbose
miglitol
voglibose
amylin analogs
pramlintide
GLP-1 analogs
exenatide
liraglutide
DPP-4 inhibitors
sitagliptin
linagliptin
SGLT-2 inhibitors
canagliflozin
dapagliflozin
metformin MOA
inhib glucagon, dec hepatic glucose prod
dec serum FFAs
reduced glucose absorption from GI
dir stim of glycolysis in tissues
metformin AE
GI upset
lactic acidosis
sulfonylureas MOA
close K+ chan in B cell –> inc resting potential –> depolarization –> inc insulin release indep of [glucose]
sulfonylureas AE
hypOglycemia
weight gain
flushing
hypOnatremia
sulfonylurea drug that is high risk in elderly/poor renal function
glyburide
meglitinides MOA
close K+ chan in B cell –> inc resting potential –> depolarization –> inc insulin release indep of [glucose]
meglitinides AE
hypOtn
thiazolidinediones MOA
TZOs bind to PPAR-gamma r (m./liver/adipocytes) –> inc insulin sensitivity and inc adiponectin
thiazolidinediones AE
weight gain
fluid retention
glucosidase inhibitors MOA
compete with intestinal alpha-glucosidases which normally hydrolyze starches/oligo/disach –> slows absorption of glucose at distal SI
glucosidase inhibitors AE
GI upset (diarrhea, flatulence)
amylin analogs MOA
suppress glucagon release
delay gastric emptying
reduce appetite
–> insulin able to work more effectively
amylin analogs AE
hypOglycemia
N/V/anorexia